electroCore Expands Intellectual Property Portfolio
ROCKAWAY, N.J., Dec. 26, 2023 (GLOBE NEWSWIRE) — electroCore, Inc. (Nasdaq:ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced that it has received patent issue notifications from the United States Patent and Trademark Office (USPTO). The two patents were issued on December 26, 2023, and relate to electroCore’s non-invasive vagus nerve stimulation (nVNS) technology:
Related news for (ECOR)
- electroCore Completes Acquisition of NeuroMetrix, Gaining Access to its Quell Platform, Creating Significant Player in Non-Invasive Bioelectronic Technologies
- electroCore’s Truvaga™ Now Works with the Apple Health app
- electroCore Named One of The Americas’ Fastest Growing Companies by the Financial Times
- electroCore Extends VA Contract for Five Years
- electroCore Announces Full Year 2024 Financial Results